Disseminated Gonococcal Infection: The Return of a Rare STI

Dr. David Alexander & Irene Martin | April 5, 2022 12-1pm ET

Gonorrhea rates in Manitoba and Saskatchewan are consistently 2-3 fold higher than the Canadian average. In Manitoba,absolute case counts soared from 2015 to 2020–which partially explains why we’re seeing more disseminated gonococcal infection (DGI). However, it’s not the whole story, there does seem to be something special about the strains associated with disseminated infections.

Learning objectives: (1) Discuss the changing epidemiology of gonorrhoea in Canada. (2) Review the clinical features of disseminated gonococcal infection. (3) Discuss the diagnosis and treatment of disseminated gonococcal infection. (4) Describe the features of Neisseria gonorrhoeae strains associated with disseminated gonococcal infection.

ABOUT THE SPEAKER: Dr. David Alexander

Scientist, Cadham Provincial Laboratory

Dr. David Alexander is a PhD-trained microbiologist with a long-standing interest in the epidemiology of infectious diseases. For the past 15years, he has worked in the provincial public health laboratory system, first at the Public Health Ontario Laboratories in Toronto and then at the Saskatchewan Disease Control Laboratory in Regina. Since 2016, David has been a Scientist at the Cadham Provincial Laboratory in Manitoba. In pre-pandemic times, his work focused on provincial surveillance of foodborne illness and sexually transmitted infections.


ABOUT THE SPEAKER: Irene Martin

Streptococcus and STI Unit @National Microbiology Laboratory, Public Health Agency of Canada

As Head of the Streptococcus and STI Unit, Irene provides laboratory reference and surveillance services including bacteriological and molecular characterizations for Neisseria gonorrhoeae, Mycoplasma genitalium, Streptococcus pneumoniae,Streptococcus pyogenes, and Streptococcus agalactiae. Research and development includes: a Streptococcus and Gonococcus genomics program; development of novel molecular diagnostic assays to detect antimicrobial resistance in clinical specimens;characterizing antimicrobial resistance mechanisms and monitoring emerging resistances.


ABOUT THE MODERATOR: Dr. Marc Steben

Family physician, president of IUSTI Canada and president elect International Society for STD Research

As a family physician, Marc concentrates his clinical interest on sexual health,mainly chronic genital diseases. Research,development and publications field include therapeutic approaches to chronic genital pain, prevention and treatment of genital herpes and development of HPV prophylactic vaccine.

Previous
Previous

The GetaKit Project: At-Home HIV Self-Testing & STI Expansion in Ontario

Next
Next

HIV cascade of care: integrating lessons learned from COVID-19 pandemic